 NEW YORK, Sept. 23, 2021 PRNewswire -- Mind Medicine MindMed Inc. NASDAQ: MNMD, NEO: MMED, DE: MMQ the Company, a leading biotech company developing psychedelic-inspired therapies, is pleased to announce that Dr. Matthias Liechti presented data from several ongoing studies at the INSIGHT Conference in Berlin, Germany. 